An increased risk of bladder cancer is linked to the use of pioglitazone, a medication commonly used to treat Type 2 diabetes, according to a new study.
An increased risk of bladder cancer is linked to the use of pioglitazone, a medication commonly used to treat Type 2 diabetes, according to a new study.